Model 3, which adjusted for additional comorbidities including hypertension and diabetes, confirmed the significance of baseline PTH levels ≥166 ng/L (HR 2.07, 95% CI 1.16–3.68, p = 0.01) as a predictive factor. The gene discussed is PTH; the disease is Hypertension.